Dopamine Agents (poisoning) < Dopamine Agents (therapeutic use) < Dopamine Agents (toxicity)

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]

Ident.	Authors (with country if any)	Title
000073 (1999)	M. Gentil [France] ; C L Tournier ; P. Pollak ; A L Benabid	Effect of bilateral subthalamic nucleus stimulation and dopatherapy on oral control in Parkinson's disease.
000244 (2002)		Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
000406 (2003)	N V Fedorova	[Use of pronoran (piribedil) in Parkinson's disease: the results of a multicenter study].
000431 (2004)	K. Ashkan [France] ; B. Wallace ; B A Bell ; A L Benabid	Deep brain stimulation of the subthalamic nucleus in Parkinson's disease 1993-2003: where are we 10 years on?
000457 (2004)	Alan L. Whone [Royaume-Uni] ; Dale L. Bailey ; Philippe Remy ; Nicola Pavese ; David J. Brooks	A technique for standardized central analysis of 6-(18)F-fluoro-L-DOPA PET data from a multicenter study.
000479 (2004)	Stéphane Thobois [France] ; François Vingerhoets ; Valerie Fraix ; Jing Xie-Brustolin ; Hélène Mollion ; Nicolas Costes ; Patrick Mertens ; Alim-Louis Benabid ; Pierre Pollak ; Emmanuel Broussolle	Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.
000576 (2005)	Mathias Pessiglione [France] ; Virginie Czernecki ; Bernard Pillon ; Bruno Dubois ; Michael Schüpbach ; Yves Agid [France] ; Léon Tremblay	An effect of dopamine depletion on decision-making: the temporal coupling of deliberation and execution.
000631 (????)	J L Montastruc [France]	Recent advances in the clinical pharmacology of Parkinson's disease.
000773 (2008)	Grégory Porras [France] ; Erwan Bezard	Preclinical development of gene therapy for Parkinson's disease.
000865 (2008)	Rogério Beato [France] ; Richard Levy ; Bernard Pillon ; Christine Vidal ; Sophie Tezenas Du Montcel ; Bernard Deweer ; Anne-Marie Bonnet ; Jean-Luc Houeto ; Bruno Dubois ; Francisco Cardoso	Working memory in Parkinson's disease patients: clinical features and response to levodopa.
000972 (2009)	T D H Lbig [France] ; W. Tse ; P G Frisina ; B R Baker ; E. Hollander ; H. Shapiro ; M. Tagliati ; W C Koller ; C W Olanow	Subthalamic deep brain stimulation and impulse control in Parkinson's disease.
000A49 (2009)	Paul Sauleau [France] ; Emmanuelle Leray ; Tiphaine Rouaud ; Sophie Drapier ; Dominique Drapier ; Sophie Blanchard ; Gwenolla Drillet ; Julie Péron ; Marc Vérin	Comparison of weight gain and energy intake after subthalamic versus pallidal stimulation in Parkinson's disease.
000A64 (2010)	D. Devos [France] ; R. Bordet ; L. Defebvre	[Pharmacological hypotheses and therapeutic strategies for gait disorders in Parkinson's disease].
000B88 (2010)	F. Vacherot [France] ; S. Attarian ; A. Eusebio ; J-P Azulay	Excitability of the lower-limb area of the motor cortex in Parkinson's disease.
000B98 (2010)	S. Thobois [France] ; C. Ardouin ; E. Schmitt ; E. Lhommée ; H. Klinger ; J. Xie ; C. Lagrange ; A. Kistner ; M. Aya Kombo ; V. Fleury ; A. Poisson ; V. Fraix ; E. Broussolle ; P. Pollak ; P. Krack	[Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment].
000C11 (2010)	P. Remy [France]	[Functional imaging: role for the diagnosis and therapeutic evaluation of Parkinson's disease].
000C21 (2010)	P. Payoux [France] ; C. Brefel-Courbon ; F. Ory-Magne ; W. Regragui ; C. Thalamas ; S. Balduyck ; F. Durif ; J P Azulay ; F. Tison ; O. Blin ; J P Esquerre ; O. Rascol	Motor activation in multiple system atrophy and Parkinson disease: a PET study.
000D32 (2011)	Olivier Rascol [France] ; Andres Lozano ; Matthew Stern ; Werner Poewe [Autriche]	Milestones in Parkinson's disease therapeutics.
001019 (2012)	Emilie Favre [France] ; Bénédicte Ballanger [France] ; Stéphane Thobois [France] ; Emmanuel Broussolle [France] ; Philippe Boulinguez [France]	Deep Brain Stimulation of the Subthalamic Nucleus, but not Dopaminergic Medication, Improves Proactive Inhibitory Control of Movement Initiation in Parkinson's Disease
001086 (2013)	Alexandre Eusebio [France] ; Tatiana Witjas ; Julien Cohen ; Frédérique Fluchère ; Elisabeth Jouve ; Jean Régis ; Jean-Philippe Azulay	Subthalamic nucleus stimulation and compulsive use of dopaminergic medication in Parkinson's disease.
001354 (2014)	Sylvia Navailles [France] ; Giuseppe Di Giovanni ; Philippe De Deurwaerdère	Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson's disease.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Dopamine Agents (therapeutic use)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Dopamine Agents (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopamine Agents (therapeutic use)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024